Literature DB >> 10660598

Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70.

A C Saphire1, T Guan, E C Schirmer, G R Nemerow, L Gerace.   

Abstract

Adenovirus, a respiratory virus with a double-stranded DNA genome, replicates in the nuclei of mammalian cells. We have developed a cytosol-dependent in vitro assay utilizing adenovirus nucleocapsids to examine the requirements for adenovirus docking to the nuclear pore complex and for DNA import into the nucleus. Our assay reveals that adenovirus DNA import is blocked by a competitive excess of classical protein nuclear localization sequences and other inhibitors of nuclear protein import and indicates that this process is dependent on hsc70. Previous work revealed that the hexon (coat) protein of adenovirus is the only major protein on the surface of the adenovirus nucleocapsid that docks at the nuclear pore complex. This, together with our finding that in vitro nuclear import of hexon is inhibited by an excess of classical nuclear localization sequences, suggests a role for the hexon protein in adenovirus DNA import. However, recombinant transport factors that are sufficient for hexon import in permeabilized cells do not support DNA import, indicating that there are other as yet unidentified factors required for this process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660598     DOI: 10.1074/jbc.275.6.4298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Heat shock cognate protein 70 is involved in rotavirus cell entry.

Authors:  Carlos A Guerrero; Daniela Bouyssounade; Selene Zárate; Pavel Isa; Tomás López; Rafaela Espinosa; Pedro Romero; Ernesto Méndez; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Association of adenovirus with the microtubule organizing center.

Authors:  Christopher J Bailey; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals.

Authors:  Harald Wodrich; Tinglu Guan; Gino Cingolani; Dan Von Seggern; Glen Nemerow; Larry Gerace
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

5.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

Review 7.  Intracellular transport of hepatitis B virus.

Authors:  Michael Kann; Andre Schmitz; Birgit Rabe
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

8.  Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways.

Authors:  Harald Wodrich; Aurelia Cassany; Maximiliano A D'Angelo; Tinglu Guan; Glen Nemerow; Larry Gerace
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Herpes simplex virus replication: roles of viral proteins and nucleoporins in capsid-nucleus attachment.

Authors:  Anna Maria Copeland; William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 10.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.